michael f demane  wayzata mn  intelius sign in we found michael f demane in wayzata mn michael f demane intelius found that michael f demane is a male between  and  years old from wayzata mn we have connected them to  addresses  phones and  relatives or associates get report now age michael f demane is in his s michael has lived in wayzata mn plattsburgh ny memphis tn michaels relatives mark demane peter demane scott demane stephen demane michael f demane zodiac signgemini gendermale professional status mb venture partners  llc get report now want to know more about michael get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about michael or use our people search engine to find others get background check on michael f demane get a criminal check on michael f demane get a public record report on michael f demane get a people search report on michael f demane michael f demanes contact information known cities lived in find out where michael f demane has lived as well as michael f demanes phone numbers and email addresses michael f demane has lived in  states minnesota address for michael f demane  s a wayzata mn has lived in wayzata mn plattsburgh ny get full address report phone numbers associated with michael f demane    wayzata mn    avon co    memphis tn get full phone report email addresses associated with michael f demane mecom dlcom get email report michael f demanes professional information information regarding michael f demanes professional history find out previous places michael f demane has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act michael f demane has worked at  places company mb venture partners  llc company medtronic  inc title president michael f demanes experience title company mb venture partners  llc job details mb venture partners is a memphisbased venture capital firm that provides capital and strategic direction to life sciences companies the firm invests in medical device and biotechnology companies at all stages of development we are especially interested in funding product solutions for musculoskeletal disease in fact we have hosted the annual musculoskeletal new ventures conference in memphis for the last  years the firm was founded by joseph r pitt hyde iii and gary stevenson in  and has since raised four funds totaling more than  million in committed capital under management to date we have invested in more than  startups about half of which are in the state of tennessee mb venture partners has funded some of the states most successful life science companies including memphisbased gtx and nashvillebased biomimetic therapeutics which was recently purchased by wright medical mb venture partners is one of the ten firms selected for the tninvestco program we have collaborated with innova memphis on the zeroto accelerator the countrys first medical device accelerator program title president company medtronic  inc job details additional professional information on michael f demane see michael f demanes linkedin profile michael f demanes social network and potential email matches find out potential social network profiles and potential email usernamed for michael f demane michael f demanes known social networks and potential email matches find all of michael f demanes social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches michael demane username matches michaeldemane demanemichael michaeldemane demanemichael michaeldemane demanemichael michaeldemane demanemichael mdemane popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m demane intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here michael f demane executive profile  biography  bloomberg july    pm et healthcare equipment and supplies company overview of medtronic sofamor danek usa inc snapshotpeople  overviewboard memberscommittees executive profile michael f demane president medtronic sofamor danek usa incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr michael f demane served as the chief executive officer of nevro corp from march  to june   and served as its executive chairman since june   until january   and served as its president since march  mr demane served as consultant at lanx inc since july  he served as president of medtronic sofamor danek usa inc he served as senior vice president of medtronic minimed inc since august  he served as the chief operating officer  of medtronic plc formerly medtronic inc from august   to april   prior this mr demane served at medtronic plc as senior vice president from august  to august   president of europe canada latin america and emerging markets from august  to may  president of ent and snt from february  to august  and president of spinal from january  to february  prior to that he was president of interbody technologies a division of medtronic sofamor danek inc from june  to december  he served as senior advisor of thomas mcnerney  partners from march  to june  prior to joining medtronic plc in  he served as the managing director of operations in australia and new zealand and president of the orthopedic implant division for smith  nephew pty ltd from april  to june  after a series of research and development and general management positions with smith  nephew inc he has held a variety of executive positions with smith  nephew pty ltd and smith  nephew orthopaedics he has been the nonexecutive chairman of nevro corp since november  and previously served as its chairman of the board since november  to june   he has been a director of synaptive medical inc since march   he serves as a director of safe orthopaedics sa he has been a director of eresearchtechnology inc since july   he has been a director of nevro corp since march  he serves as a board member of cardionomic he served as a member of financial advisory board at mb venture partners llc and a director of torax medical inc he served as a director of rotation medical inc he received his ms in bioengineering from clemson university and his bs in chemistry from st lawrence university continued his studies in engineering at the university of texas mr demane later completed an advanced management program at the insead school of management in fontainebleau franceread full background corporate headquarters  pyramid placememphis tennessee united statesphone fax  board members memberships directorrotation medical incdirectorsafe orthopaedics sapresentdirectoreresearchtechnology incpresentnonexecutive chairmannevro corppresentdirectorsynaptive medical inc education unknownother education the university of texas systemms clemson universitybs st lawrence university other affiliations medtronic plcmedtronic minimed incsofamor danek group incthe university of texas systemeresearchtechnology incthomas mcnerney  partnersmb venture partnersclemson universityst lawrence universitysmith  nephew inctorax medical incnevro corplanx incrotation medical incsafe orthopaedics sasynaptive medical inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact medtronic sofamor danek usa inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close ﻿ envestnet asset management inc sells  shares of nevro corp nvro  markets daily daily ratings  news for nevro corp complete the form below to receive the latest headlines and analysts recommendationsfor nevro corp with our free daily email newsletter follow themarketsdaily the markets daily recent posts kcg holdings inc has  position in masimo corporation nasdaqmasi bank of new york mellon corp decreases stake in intracellular therapies inc itci ubs group ag buys  shares of potlatch corporation pch fmr llc purchases  shares of pinnacle foods inc pf national retail properties nnn stake reduced by pnc financial services group inc spx corp nasdaqspxc shares bought by thrivent financial for lutherans rex american resources corporation nyserex shares sold by california public employees retirement system pnc financial services group inc has  position in first data corporation fdc dxp enterprises inc dxpe stake increased by principal financial group inc fmr llc has  stake in great ajax corp ajx legal  general group plc has  million position in veeco instruments inc nasdaqveco texas instruments incorporated nasdaqtxn stake maintained by ifm investors pty ltd halliburton company nysehal shares bought by mitchell group inc general dynamics corporation nysegd position lowered by pnc financial services group inc grubhub inc grub position reduced by amalgamated bank career education corporation ceco shares bought by principal financial group inc bowling portfolio management llc sells  shares of international business machines corporation ibm american international group inc raises stake in park sterling corporation nasdaqpstb obermeyer wood investment counsel lllp maintains position in mondelez international inc mdlz schwab charles investment management inc has  million stake in herbalife ltd hlf envestnet asset management inc sells  shares of nevro corp nvro posted by sarita garza on jul th   no comments envestnet asset management inc lowered its position in nevro corp nysenvro by  during the first quarter according to its most recent form f filing with the securities and exchange commission the fund owned  shares of the medical equipment provider’s stock after selling  shares during the period envestnet asset management inc’s holdings in nevro corp were worth  at the end of the most recent quarter other hedge funds have also bought and sold shares of the company fortaleza asset management inc bought a new stake in shares of nevro corp during the first quarter valued at  ameritas investment partners inc purchased a new position in shares of nevro corp during the first quarter valued at  massmutual trust co fsb adv raised its position in nevro corp by  in the first quarter massmutual trust co fsb adv now owns  shares of the medical equipment provider’s stock worth  after buying an additional  shares during the period first republic investment management inc raised its position in nevro corp by  in the fourth quarter first republic investment management inc now owns  shares of the medical equipment provider’s stock worth  after buying an additional  shares during the period finally princeton alpha management lp bought a new position in nevro corp during the first quarter worth  get nevro corp alerts nevro corp nvro opened at  on tuesday the firm’s  day moving average is  and its day moving average is  the company’s market cap is  billion nevro corp has a  week low of  and a  week high of  nevro corp nysenvro last issued its quarterly earnings results on monday may th the medical equipment provider reported  earnings per share eps for the quarter missing the zacks’ consensus estimate of  by  nevro corp had a negative net margin of  and a negative return on equity of  the company had revenue of  million for the quarter compared to analyst estimates of  million during the same quarter in the previous year the company posted  eps the company’s revenue for the quarter was up  compared to the same quarter last year on average analysts predict that nevro corp will post  earnings per share for the current fiscal year warning “envestnet asset management inc sells  shares of nevro corp nvro” was originally posted by markets daily and is the sole property of of markets daily if you are viewing this news story on another site it was illegally copied and republished in violation of us and international copyright  trademark legislation the original version of this news story can be accessed at httpswwwthemarketsdailycomnevrocorpnvrosharessoldbyenvestnetassetmanagementincupdatedhtml a number of research firms have recently weighed in on nvro bidaskclub raised nevro corp from a “sell” rating to a “hold” rating in a research note on sunday canaccord genuity reaffirmed a “buy” rating and issued a  target price on shares of nevro corp in a report on wednesday july th j p morgan chase  co reaffirmed an “overweight” rating and issued a  price target on shares of nevro corp in a research note on monday july rd northland securities set a  target price on nevro corp and gave the stock a “buy” rating in a research report on thursday june th finally zacks investment research cut nevro corp from a “hold” rating to a “sell” rating in a research note on saturday june rd two analysts have rated the stock with a sell rating two have assigned a hold rating and nine have issued a buy rating to the company’s stock the company currently has an average rating of “buy” and an average target price of  in other news ceo rami elghandour sold  shares of the company’s stock in a transaction dated monday may st the shares were sold at an average price of  for a total transaction of  the transaction was disclosed in a filing with the securities  exchange commission which is accessible through this link also director michael f demane sold  shares of the company’s stock in a transaction that occurred on tuesday may nd the stock was sold at an average price of  for a total value of  following the completion of the transaction the director now owns  shares of the company’s stock valued at approximately  the disclosure for this sale can be found here over the last ninety days insiders have sold  shares of company stock worth  insiders own  of the company’s stock about nevro corp nevro corp is a global medical device company the company focuses on providing products that improve the quality of life of patients suffering from chronic pain the company has developed and commercialized the senza spinal cord stimulation scs system an evidencebased neuromodulation platform for the treatment of chronic pain receive news  ratings for nevro corp daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for nevro corp and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website insider trading  demane michael f  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  demane michael f select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm nevro corp nvro demane michael fdirector    indirectdirect view sale  pm nevro corp nvro demane michael fdirector    directindirect view sale  am nevro corp nvro demane michael fdirector    directindirect view sale  pm nevro corp nvro demane michael fdirector    directindirect view sale  pm nevro corp nvro demane michael fdirector    directindirect view sale  am nevro corp nvro demane michael fdirector    directindirect view sale  pm nevro corp nvro demane michael fchief executive officerdirector    direct view sale  pm nevro corp nvro demane michael fchief executive officerdirector    directindirect view sale  pm nevro corp nvro demane michael fchief executive officerdirector    directindirect view sale  pm nevro corp nvro demane michael fchief executive officerdirector    directindirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm nana nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view exercise  pm na nevro corp nvro demane michael fdirector   direct view option award  pm na nevro corp nvro demane michael fchief executive officerdirector   direct view   secformcom all rights reserved archives        sat  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  michael f demane  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in michael f demane chairman of the board at nevro corp view full profile are you michael f demane claim your profile   sign up for equilar atlas and view michael f demanes full profile with equilar atlas you can identify corporate executives in michael f demanes network and community follow changes in michael f demanes employment and moneyinmotion connect with michael f demane through your network of contacts michael f demanes executive work history current chairman of the board nevro corp past to view michael f demanes complete executive work history sign up now age      michael f demanes biography michael demane joined us in march  as chief executive officer until november  at which time he became chairman and chief executive officer of the company in june  mr demane assumed the role of executive chairman of the board until january  at which time he became chairman of the board mr demane has served on the boards of directors of several private companies since  and on the board of directors of eresearch technology inc a public company specializing in contract research clinical services from july  to april  from march  to june  mr demane served as a senior advisor to thomas mcnerney   read more michael demane joined us in march  as chief executive officer until november  at which time he became chairman and chief executive officer of the company in june  mr demane assumed the role of executive chairman of the board until january  at which time he became chairman of the board mr demane has served on the boards of directors of several private companies since  and on the board of directors of eresearch technology inc a public company specializing in contract research clinical services from july  to april  from march  to june  mr demane served as a senior advisor to thomas mcnerney  partners a healthcare venture firm mr demane served as the chief operating officer of medtronic inc from august  to april  prior to his coo role mr demane served at medtronic inc as senior vice president from may  to august  senior vice president and president europe canada latin america and emerging markets from august  to may  senior vice president and president spinal ent and navigation from february  to august  and president spinal from january  to february  prior to that he was president interbody technologies division a division of medtronic sofamor danek inc from june  to december  mr demane served at smith  nephew pty ltd as managing director australianew zealand from april  to june  mr demane was president of the orthopaedic implant division of smith  nephew orthopaedics from march  to april  prior to that he was vice president orthopaedic research and development for smith  nephew orthopaedics from june  until march  mr demane earned a bs in chemistry from st lawrence university and an ms in bioengineering from clemson university we believe that mr demane is qualified to serve on our board due to his investment experience strategic leadership track record service on other boards of directors of companies in the healthcare industry and his service as our chief executive officer source nevro corp on    sign up for equilar atlas and view michael f demanes full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like michael f demane more specifically youll be able to identify corporate executives in michael f demanes network and community follow changes in michael f demanes employment and moneyinmotion connect with michael f demane through your network of conections view full profile   search for over  executive profiles bio example michael f demane michael f demanes connections  sign up now to view michael f demanes  connections » robert l ryan board member general mills inc david j scott former svp general counsel and secretary amgen inc james t lenehan board member medtronic plc richard h anderson board member medtronic plc robert c pozen board member medtronic plc david l calhoun chairman of the board caterpillar inc denise m oleary board member medtronic plc martha g aronson board member hutchinson technology inc kendall j powell chairman of the board general mills inc arthur d collins board member us bancorp popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company claiborne p deming chairman of the board murphy oil corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   nvro michael f demane insider trades for nevro corp bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close nevro corp nyse nvro go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus nevro corp after hours  quotes are delayed by  min jul    pm nvro quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual michael f demane mr michael f demane is chairman at nevro corp he is on the board of directors at safe orthopaedics sas cardionomic inc and rotation medical inc mr demane was previously employed as chairman  chief executive officer by lanx inc an independent director by eresearchtechnology inc chief operating officer by medtronic inc and managing directoraustralia  new zealand regions by smith  nephew plc he also served on the board at medtronic sofamor danek inc and torax medical inc he received his undergraduate degree from st lawrence university and a graduate degree from clemson university transactions date shares transaction value     award at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr michael f demane chairman mr rami elghandour president chief executive officer  director mr patrick schmitz vice presidentoperations mr andrew h galligan chief financial officer dr david caraway chief medical officer mr bradford e gliner vice presidentclinical  regulatory mr christopher christoforou vice presidentresearch  development mr doug alleavitch vice presidentquality mr andre walker senior vice presidentresearch  development mr neeraj teotia vice presidentmarketing mr richard b carter vice presidentfinance  corporate controller ms katherine bock senior director corporate development ms divyasmita ghatak vice presidenthuman resources mr michael w hall general counsel ms lisa d earnhardt independent director dr brad h vale independent director mr shawn t mccormick independent director dr ali behbahani independent director mr frank m fischer independent director dr wilfred e jaeger independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  michael demane  nevro corp  zoominfocom   michael demane  mb venture partners  llc  zoominfocom nevro corp nysenvro stock price news  analysis  marketbeat nevro corp company profile nysenvro company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about nevro corp nysenvro nevro corp is a global medical device company the company focuses on providing products that improve the quality of life of patients suffering from chronic pain the company has developed and commercialized the senza spinal cord stimulation scs system an evidencebased neuromodulation platform for the treatment of chronic pain its hf therapy is designed to deliver neuromodulation solutions for treating chronic pain hf therapy enables patients to achieve sustained pain relief without paresthesia thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia hf therapy relies on consistent anatomical lead placement as of december   it was investigating the use of hf therapy to address additional indications such as chronic upper limb and neck pain painful neuropathies and nonsurgical refractory back pain the senza system is approved to create electrical impulses from  hertz hz to  hz industry sector and symbol sector medical industry medical equipment supplies  distribution  nec subindustry na symbol nysenvro cusip na web wwwnevrocom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio naforeward pe ratio pe growth sales  book valueannual revenue  millionprice  sales book value  per shareprice  book  profitabilityebidta net margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  shsbeta short ratio    frequently asked questions for nevro corp nysenvro what is nevro corps stock symbol nevro corp trades on the new york stock exchange nyse under the ticker symbol nvro how were nevro corps earnings last quarter nevro corp nysenvro issued its earnings results on monday may th the company reported  eps for the quarter missing the consensus estimate of  by  the company had revenue of  million for the quarter compared to analysts expectations of  million nevro corp had a negative return on equity of  and a negative net margin of  nevro corps revenue for the quarter was up  on a yearoveryear basis during the same quarter in the previous year the firm posted  earnings per share view nevro corps earnings history where is nevro corps stock going where will nevro corps stock price be in   analysts have issued  month price targets for nevro corps stock their forecasts range from  to  on average they expect nevro corps share price to reach  in the next year view analyst ratings for nevro corp what are analysts saying about nevro corp stock here are some recent quotes from research analysts about nevro corp stock  according to zacks investment research nevro corp is a medical device company it engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain the company provides pain relief to the customers suffering from low back pain and types of chronic pains nevro has developed and commercialized the senza r spinal cord stimulation scs system for the treatment of chronic pain senza hf nevro and the nevro logo are trademarks of the company nevro corp is headquartered in menlo park california    northland securities analysts commented the widely awaited release of boston scientifics accelerate study data on the q call today was a downer strangely enough the company stated on its call that it would continue enrolling patients in the trial expects enrollment to finish by end of fy and data release by mid suffice it to say the anticlimax will be perceived as something being off in the accelerate study hence being positive for nevrothe analyst speculated that something is off in the accelerate study causing a delay in datarelease here are some thoughts  questionsis boston sci increasing the sample size in the trial was there a subgroup analysis done and investigators realized that the bellcurve on lead placements was not on t  t locations hence pain relief was suboptimal will there now be more anatomical placement on t  t with its hf arm in essence is boston sci converging on nevros secret sauce  who are some of nevro corps key competitors some companies that are related to nevro corp include vwr corporation vwr integra lifesciences holdings corporation iart nuvasive nuva icu medical icui livanova plc livn neogen corporation neog haemonetics corporation hae inogen ingn halyard health hyh mimedx group mdxg conmed corporation cnmd asante solutions pump cardiovascular systems csii km group holdings ktwo orasure technologies osur orthofix international nv ofix atricure atrc and intersect ent xent who are nevro corps key executives nevro corps management team includes the folowing people rami elghandour president chief executive officerandrew h galligan chief financial officerpatrick schmitz vice president  operationsmichael enxing vice president of salesdouglas a alleavitch vice president  quality and operationschristopher christoforou vice president  research and developmentali behbahani md independent directorlisa d earnhardt independent directorfrank m fischer independent directorwilfred e jaeger md independent director who owns nevro corp stock nevro corps stock is owned by a variety of of retail and institutional investors top institutional shareholders include peregrine capital management llc  bank of montreal can  gradient investments llc  quantitative systematic strategies llc  inspirion wealth advisors llc  and us bancorp de  company insiders that own nevro corp stock include andre walker andrew h galligan brad vale doug alleavitch michael enxing michael f demane rami elghandour and wilfred e jaeger view institutional ownership trends for nevro corp who sold nevro corp stock who is selling nevro corp stock nevro corps stock was sold by a variety of institutional investors in the last quarter including creative planning company insiders that have sold nevro corp stock in the last year include andrew h galligan doug alleavitch michael enxing michael f demane rami elghandour and wilfred e jaeger view insider buying and selling for nevro corp who bought nevro corp stock who is buying nevro corp stock nevro corps stock was acquired by a variety of institutional investors in the last quarter including peregrine capital management llc gradient investments llc quantitative systematic strategies llc bank of montreal can inspirion wealth advisors llc and us bancorp de view insider buying and selling for nevro corp how do i buy nevro corp stock shares of nevro corp can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is nevro corps stock price today one share of nevro corp stock can currently be purchased for approximately  marketbeat community rating for nevro corp nyse nvrocommunity ranking   out of    outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about nevro corp and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for nevro corp nysenvro how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold rating  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for nevro corp nysenvro show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailscanaccord genuityreiterated ratingbuyhighj p morgan chase  coreiterated ratingoverweightlownorthland securitiesset price targetbuylowb rileydowngradeneutrallowleerink swannboost price targetoutperform  napiper jaffray companiesreiterated ratingoverweight  najmp securitiesboost price targetmarket outperform  nabmo capital marketsreiterated ratingbuynabank of america corporationinitiated coveragebuynawilliam blairreiterated ratingoutperformnawells fargo  companyinitiated coverageoutperformnamorgan stanleyreiterated ratingbuynasterne agee crtreiterated ratingbuynadata available from  forward earnings earnings history for nevro corp nysenvroearnings history by quarter for nevro corp nyse nvrodatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsq  million millionviewlistenq million millionviewnaq million millionviewlistenq million millionviewnaq million millionviewnaq million millionviewlistenq million millionviewnaq million millionviewnaq million millionviewlistenq  millionviewnadata available from  forward estimates earnings estimates for nevro corp nysenvrocurrent year eps consensus estimate  epsnext year eps consensus estimate  eps dividends dividend history for nevro corp nysenvrono dividend announcements for this company have been tracked by marketbeatcom insider trades insider trading and institutional ownership history for nevro corp nysenvroinsider ownership percentage insider trades by quarter for nevro corp nysenvrotransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsandrew h galligancfosell  michael f demanedirectorsell  rami elghandourceosell  michael enxingvpsell  michael f demanedirectorsell  andrew h galligancfosell  michael enxingvpsell  wilfred e jaegerdirectorsell  michael enxingvpsell  michael enxingvpsell  andrew h galligancfosell  rami elghandourceosell  michael f demanedirectorsell  michael enxingvpsell  doug alleavitchvpsell  wilfred e jaegerdirectorsell  wilfred e jaegerdirectorsell  andrew h galligancfosell  doug alleavitchvpsell  michael f demanedirectorsell  michael enxingvpsell  doug alleavitchvpsell  michael f demanedirectorsell  doug alleavitchvpsell  michael f demanedirectorsell  michael enxingvpsell  michael f demanedirectorsell  doug alleavitchvpsell  rami elghandourceosell  michael enxingvpsell  andre walkervpsell  doug alleavitchvpsell  wilfred e jaegerdirectorsell  andrew h galligancfosell  michael f demaneceosell  rami elghandourpresidentsell  michael enxingvpsell  michael enxingvpsell  rami elghandourpresidentsell  andre walkervpsell  doug alleavitchvpsell  andre walkervpsell  rami elghandourpresidentsell  andre walkervpsell  andre walkervpsell  andre walkervpsell  rami elghandourpresidentsell  andre walkervpsell  andre walkervpsell  wilfred e jaegerdirectorsell  wilfred e jaegerdirectorsell  michael f demaneceosell  brad valedirectorbuy  andre walkervpsell  michael f demaneceosell   johnson johnsonmajor shareholdersell  bay city capital llcinsidersell  wilfred e jaegerdirectorsell   johnson johnsonmajor shareholderbuy  as novoinsiderbuy  data available from  forward headlines headline trends for nevro corp nysenvro latest headlines for nevro corp nysenvro source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlinereviewing biorad laboratories bio and nevro corp nvrowwwamericanbankingnewscom  july  at  amnevro corp nvro upgraded to hold at bidaskclubwwwamericanbankingnewscom  july  at  pmnevro corp nvro shares cross above  dmawwwnasdaqcom  july  at  ammedical equipment stock performance review  nevro enteromedics avinger and viewraywwwprnewswirecom  july  at  amnevro nvro surges stock moves  higher  nasdaqwwwnasdaqcom  july  at  pmetfs with exposure to nevro corp  july  financeyahoocom  july  at  pmnevro corp breached its  day moving average in a bullish manner  nvrous  july  financeyahoocom  july  at  amhealth care sector update for  nvromtbcbgne  nasdaqwwwnasdaqcom  july  at  ambuzzus stocks on the move tesla diebold nixdorf nevro   nasdaqwwwnasdaqcom  july  at  amheres why shares of nevro corp nvro jumped today  nasdaqwwwnasdaqcom  july  at  amheres why shares of nevro corp nvro jumped todayfinanceyahoocom  july  at  am brokerages anticipate nevro corp nvro will post earnings of  per sharewwwamericanbankingnewscom  july  at  pmcanaccord genuity reaffirms buy rating for nevro corp nysenvrowwwamericanbankingnewscom  july  at  pmwhy nevro corp is soaring  higher todaywwwfoolcom  july  at  pmnevro announces preliminary unaudited second quarter  revenue and business update  pr newswire press releasewwwprnewswirecom  july  at  amnevro announces preliminary unaudited second quarter  revenue and business updatefinanceyahoocom  july  at  amnevro corp nysenvro given average recommendation of buy by brokerageswwwamericanbankingnewscom  july  at  amnevro corp nysenvro stock rating reaffirmed by j p morgan chase  cowwwamericanbankingnewscom  july  at  ametfs with exposure to nevro corp  june  financeyahoocom  june  at  amnevro corp nvro given a  price target at northland securitieswwwamericanbankingnewscom  june  at  pmetfs with exposure to nevro corp  june  financeyahoocom  june  at  pmnevro nvro senzarct month outcomes publication selected by neurosurgery as top pain paper of the year  streetinsidercomwwwstreetinsidercom  june  at  amneurosurgery selects the senzarct month outcomes publication as the top pain paper of the yearfinanceyahoocom  june  at  amnevro corp nvrous earnings analysis q  by the numbers  june  financeyahoocom  june  at  pm brokerages expect nevro corp nvro will announce quarterly sales of  millionwwwamericanbankingnewscom  june  at  amzacks brokerages anticipate nevro corp nvro will post earnings of  per sharewwwamericanbankingnewscom  june  at  pmnevro corp nvro receives average rating of buy from brokerageswwwamericanbankingnewscom  june  at  amzacks investment research lowers nevro corp nvro to sellwwwamericanbankingnewscom  june  at  amrelative strength alert for nevrowwwnasdaqcom  may  at  pmnevro to present at the william blair growth stock conferencefinanceyahoocom  may  at  pmnevro corp nvro downgraded by valuengine to sellwwwamericanbankingnewscom  may  at  pmzacks analysts anticipate nevro corp nvro will announce quarterly sales of  millionwwwamericanbankingnewscom  may  at  pmnevro corp nvro cfo sells  in stockwwwamericanbankingnewscom  may  at  pm eps expected for nevro corp nvro this quarterwwwamericanbankingnewscom  may  at  amb riley downgrades nevro corp nvro to neutralwwwamericanbankingnewscom  may  at  amnevro corp nvro given consensus recommendation of buy by brokerageswwwamericanbankingnewscom  may  at  amnevro corp nvro stock rating lowered by zacks investment researchwwwamericanbankingnewscom  may  at  amedited transcript of nvro earnings conference call or presentation may pm gmtfinanceyahoocom  may  at  amoversold conditions for nevro nvrowwwnasdaqcom  may  at  pmnevro corp just tumbled by as much as   heres whyfinanceyahoocom  may  at  pmmedtech player losses double that of views shares tumblefinanceyahoocom  may  at  pmnevro corp nvro releases quarterly earnings results misses expectations by  epswwwamericanbankingnewscom  may  at  pmnevro corp nvro rating reiterated by northland securitieswwwamericanbankingnewscom  may  at  amb riley downgrades nevro corp nvro to neutral citing slower usbased revenue growthwwwstreetinsidercom  may  at  amnevro reports first quarter  financial resultsfinanceyahoocom  may  at  pmnevro reports q lossmarketbeatcom  may  at  pmmedical product q earnings on may  itgr opk  morefinanceyahoocom  may  at  pmnevro corp nvro receives media impact score of wwwamericanbankingnewscom  may  at  pmrami elghandour sells  shares of nevro corp nvro stockwwwamericanbankingnewscom  may  at  pmmichael f demane sells  shares of nevro corp nvro stockwwwamericanbankingnewscom  may  at  pm social chart nevro corp nvro chart for saturday july   this page was last updated on  by marketbeatcom staff